Axonics Inc
NASDAQ:AXNX

Watchlist Manager
Axonics Inc Logo
Axonics Inc
NASDAQ:AXNX
Watchlist
Price: 70.98 USD 0.75% Market Closed
Market Cap: 3.6B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one AXNX stock under the Base Case scenario is 47.59 USD. Compared to the current market price of 70.98 USD, Axonics Inc is Overvalued by 33%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AXNX Relative Value
Base Case
47.59 USD
Overvaluation 33%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

8.4
P/S
P/S
Price to Sales
8.4
vs History
73
vs Industry
15
Median 3Y
8.6
Median 5Y
11
Industry
2.4
Forward
7.9
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-237.3
Median 5Y
-50.6
Industry
22.5
Forward
251.9
More Details
253.7
P/OCF
P/OCF
Price to OCF
253.7
vs History
11
vs Industry
1
Median 3Y
236.1
Median 5Y
-24.4
Industry
14.4
More Details
677.2
P/FCFE
P/FCFE
Price to FCFE
677.2
vs History
4
vs Industry
0
Median 3Y
184.3
Median 5Y
-24.3
Industry
21
More Details
5.5
P/B
P/B
Price to Book Value
5.5
vs History
41
vs Industry
14
Median 3Y
5.4
Median 5Y
5.5
Industry
2.3
More Details
7.6
EV/S
EV/S
Enterprise Value to Sales
7.6
vs History
71
vs Industry
16
Median 3Y
7.7
Median 5Y
9.7
Industry
2.6
Forward
7.1
More Details
9.9
EV/GP
EV/GP
Enterprise Value to Gross Profit
9.9
vs History
74
vs Industry
21
Median 3Y
10.3
Median 5Y
13.5
Industry
5.2
More Details
623.1
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
623.1
vs History
4
vs Industry
0
Median 3Y
424.4
Median 5Y
-34.1
Industry
11.9
Forward
42.4
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-413.9
Median 5Y
-63
Industry
16.5
Forward
-321 819.9
More Details
229.6
EV/OCF
EV/OCF
Enterprise Value to OCF
229.6
vs History
9
vs Industry
1
Median 3Y
205.2
Median 5Y
-21.5
Industry
14.6
More Details
610.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
610.8
vs History
4
vs Industry
0
Median 3Y
166.4
Median 5Y
-27.1
Industry
18.5
More Details
8
EV/IC
EV/IC
Enterprise Value to IC
8
vs History
61
vs Industry
10
Median 3Y
8.3
Median 5Y
8.5
Industry
1.9
More Details

Multiples Across Competitors

AXNX Competitors Multiples
Axonics Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Axonics Inc
NASDAQ:AXNX
3.6B USD 8.4 -641 623.1 -454.8
US
Abbott Laboratories
NYSE:ABT
229.7B USD 5.3 16.4 21.7 30.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
168.4B USD 18.4 64.6 50.2 60.3
US
Boston Scientific Corp
NYSE:BSX
155.7B USD 8.4 62.2 34.9 48.1
US
Stryker Corp
NYSE:SYK
147.1B USD 6.2 50.4 24.9 30.1
IE
Medtronic PLC
NYSE:MDT
116.8B USD 3.4 25.1 13.8 19.8
DE
Siemens Healthineers AG
XETRA:SHL
53.6B EUR 2.3 24.7 13.8 19.4
US
Becton Dickinson and Co
NYSE:BDX
56.4B USD 2.6 35.1 13.4 24.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
50.7B USD 12.6 51.5 37 41.1
US
Edwards Lifesciences Corp
NYSE:EW
47.6B USD 8.4 11.5 25.4 27.9
US
Resmed Inc
NYSE:RMD
42.2B USD 8.2 30.1 21.7 24.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Axonics Inc
NASDAQ:AXNX
Average EV/EBIT: 32.6
Negative Multiple: -454.8 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
30.6
23%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
60.3
27%
2.2
US
Boston Scientific Corp
NYSE:BSX
48.1
33%
1.5
US
Stryker Corp
NYSE:SYK
30.1
16%
1.9
IE
Medtronic PLC
NYSE:MDT
19.8
16%
1.2
DE
Siemens Healthineers AG
XETRA:SHL
19.4
19%
1
US
Becton Dickinson and Co
NYSE:BDX
24.2
27%
0.9
US
IDEXX Laboratories Inc
NASDAQ:IDXX
41.1
13%
3.2
US
Edwards Lifesciences Corp
NYSE:EW
27.9
13%
2.1
US
Resmed Inc
NYSE:RMD
24.7
12%
2.1

See Also

Summary
AXNX intrinsic value, competitors valuation, and company profile.
DCF Valuation
AXNX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AXNX stock valuation using valuation multiples.
Wall Street Estimates
AXNX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AXNX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 276,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.